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ABSTRACT RAG1 protein is essential for the activation
of V(D)J recombination in developing lymphocytes (V, vari-
able; D, diversity; J, joining). However, it has not been deter-
mined whether its role involves substrate recognition and
catalysis. A single amino acid substitution mutation in the
RAG) gene has now been identified that renders its activity
sensitive to the sequence of the coding region abutting the
heptamer site in the recombination signal sequence. These
results strongly imply that RAG1 interacts directly with DNA.
V(D)J recombination-the joining of DNA segments in early
lymphocytes that creates the antigen receptor genes-requires
activity of the recombination activating genes RAG1 and
RAG2 (1, 2) (V, variable; D, diversity; J, joining). These genes
are expressed almost exclusively in developing lymphocytes
that are undergoing antigen receptor gene assembly and are
the only known lymphoid-specific proteins required for the
process (1). The simultaneous expression ofRAG] and RAG2
in nonlymphoid cells is sufficient to activate V(D)J recombi-
nation activity (1). Furthermore, mice that lack either RAG1
or RAG2 fail to develop mature lymphocytes due to their
inability to initiate rearrangement of the antigen receptor
genes (3-5).
An essential step in recombination is the recognition of
specific DNA sequences (recombination signal sequences;
RSS) adjacent to the variable gene segments which appropri-
ately target the recombination events (6). The core RSS is
composed of conserved heptamer and nonamer sequences
separated by 12 or 23 nucleotides (7). Furthermore, the nucleo-
tide sequence of the coding ends can profoundly influence the
efficiency of RSS usage (8-10). During the initial steps of
recombination, chromosomally distal RSSs must be juxtaposed
and double-strand breaks introduced at the heptamer/coding
sequence junctions. Analysis of broken DNA ends in lymphoid
cells from normal and Scid (severe combined immunodefi-
ciency) mice have shown that the heptamer ends are blunt and
5' phosphorylated (11-14); in contrast, the coding ends in Scid
lymphocytes are retained as hairpins, which most likely rep-
resent normal intermediates in the catalytic pathway (13, 15).
The subsequent processing and joining of ends is dependent on
factors involved in double-strand break repair (16).
Although the exact role of RAG1 and RAG2 has remained
elusive, recent evidence has suggested that RAG1 directly acti-
vates recombination. In vitro studies have shown that recom-
binant RAG1 can promote the formation of DNA cleavage
products associated with the initial steps of V(D)J recombi-
nation when supplemented into nuclear extracts that contain
RAG2 (17). However, it is not known whether RAG1 partic-
ipates directly in the catalytic mechanism and/or activates the
recombinase. Here we provide genetic evidence that RAG1 is
directly involved in the recognition of the DNA substrate.
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MATERIALS AND METHODS
Plasmids. The RAG1 and RAG2 CDM8 eukaryotic expres-
sion vectors are described by Oettinger et al. (1). The RAG1
CDM8 expression constructs either contained or lacked a
short 5' untranslated region of the RAG1 cDNA. This extra
sequence decreased RAG1 protein expression -5-fold but had
no impact on recombination activity, as described in Results.
Site-directed mutations in RAG1 were generated by oligonu-
cleotide-mediated mutagenesis (Bio-Rad) of a single-stranded
phagemid Bluescript (Stratagene) that contained the RAG1
cDNA. For cloning convenience, we created an artificial
RlH609L allele for expression from the CDM8 vector, which
lacked the 5' untranslated region; this construct contains a new
Hindlll site at amino acid position 609 and lacks theAva I site
present in the original RlH609L (M6) allele.
The V(D)J recombination substrates pJH200 (18), pJH288,
and pJH289 (19) were the gifts of M. Gellert and J. Hesse.
Mutations in the V(D)J recombination substrates were created
by two- and three-step overlap PCR-mediated mutagenesis
(20). In creating the pJH288 derivatives, a Bgl II fragment
containing an M13 origin of replication was removed. This had
no effect on recombination activity. Sequencing of all recom-
bination substrates and RAG1 derivatives was done with an
automated sequencing apparatus (Applied Biosystems) to
confirm their integrity. The identity of the recombination
substrates is shown in Table 1.
Cell Lines and Transfections. DNA was transiently intro-
duced into the fetal human kidney carcinoma cell line 293 cells
by calcium phosphate-mediated transfection as described (21).
RAG1 and RAG2 CDM8 expression vectors (6 ,ug each) were
cotransfected with 6 ,tg of the indicated V(D)J recombination
plasmid substrate into cells plated at 2 x 106 cells per 60-mm
dish 16 hr earlier. Cells were harvested after 44-48 hr.
Transfected plasmid DNA was recovered by Hirt extraction of
cell lysates as described (18, 22). Less than a 2-fold variation
in transfection efficiency was routinely observed.
Recombination Assay. One percent of the recovered plas-
mid was subject to PCR amplification. The following oligonu-
cleotides were used to direct the amplification of signal-joint
products: RA-CR2, 5 '-TTTGTTCCAGTCTGTAGCACT-
GCGCAC-3'; RA-14, 5'-TCCAGCTGAACGGTCTGG-3'.
The oligonucleotide RA-CR2 spans most of the 12-RSS and
the signal joint generated after recombination. It contains a
mismatch (underlined) within the sequence complementary to
the 12-heptamer site (boldface), which prevents the amplifi-
cation of fragments from the unrearranged vector. RA-14 is
complementary to sequences within the chloramphenicol-
resistance gene. The PCR fragment sizes from the pJH200 and
pJH288 series are 256 and 236 bp, respectively. The following
oligonucleotides were used to detect circular (closed) excision
products for pJH200 and its derivatives: RA-CR3, 5'-
ATTGGTGAGAATCGCAGCAACTTGT-3'; OOP2, 5'-
CGGCAACCGAGCGTTCTGAAC-3'. The PCR fragment
size is 190 bp.
Abbreviations: V, variable; D, diversity; J, joining; RSS, recombination
signal sequence.
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Table 1. List of recombination substrates used in this study
Plasmid 5'-Heptamer coding sequence
pJH200 (SJ-DEL) 5'-AACCTGCACATGT-(23)-nonamer JK1
5'-AGACTGCACATGT-(12)-nonamer VKL8
pJH200J 5'-GGATCC JK1 (BamHI)
pJH200V(ApaLI) 5'-GTGCAC VKL8 (ApaLI)
pJH200V(SalI) 5'-GTCGAC VKL8 (Sal I)
pJH200JV(SalI)
pJH200JV(ApaLI)
pJH288 (INV) 5'-GGATCC JK1 (BamHI)
pJH289 (SJ-DEL) 5'-GTCGAC VKL8 (Sal I)
pJH288J 5'-GGAGTG JK1
pJH288V 5'-GTCGTG VKL8
pJH288JV
pDGR (INV) 5'-GTCCAC JK1
5'-TCCTCC VK21-C
Plasmid name is indicated in the left column, with parental vectors
listed in boldface type. Coding-end sequences 5' of the indicated
heptamer for specified plasmids are listed in the right column; relevant
sequences from pJH200 are shown more completely as a model for
those below them. The 12-RSS is from VKL8, and the 23-RSS is from
JK1 (see ref. 18 for details). Heptamer sequence is underlined, and the
spacer number is given in parentheses. Two nucleotides in boldface are
the two nucleotides 5' to the heptamer. SJ-DEL, signal-joint retaining
deletion substrate; INV, inversion substrate. For the pJH200 and
pJH288 derivatives, a J and/or V is added to the plasmid name to
indicate at which heptamer the coding-end changes were made. The
two coding-end changes at the 12-heptamer in pJH200 are indicated
by the restriction site used to create the coding-end changes in
parentheses preceded by a V. Restriction sites for the pJH200 deriv-
atives are adjacent to the heptamer sites, as they are in pJH288. The
ApaLI sites in the pJH288 derivatives span the coding end and
heptamer (GTGCAC). The coding-ends of pDGR are shown for
comparison.
A 25-,ul PCR amplification reaction mixture contained 10
mM Tris HCl (pH 8.3), 50 mM KCI, 5.5 mM MgCl2, 0.1 mg of
acetylated bovine serum albumin per ml, 100 ng of each
oligonucleotide, 20 ,uM each dNTP, 2 ,tCi of [a-32P]dCTP
(3000 Ci/mmol; 1 Ci = 37 GBq; Amersham), and 1 unit of Taq
DNA polymerase (Boehringer Mannheim) and was subject to
the following amplification profile: 94°C for 30 sec and 72°C
for 2 min x 22 cycles; 72°C for 10 min. The radiolabeled
products were resolved by electrophoresis through a 5%
polyacrylamide gel in 0.5 x TBE. Bands were visualized by
autoradiography and quantitated by PhosphorImaging (Mo-
lecular Dynamics).
R1WT and mutant constructs were always transfected in
parallel. To obtain relative values for recombination activity,
the amount of the fragment amplified from the R1WT sample,
as reflected in the band intensity detected by PCR and
PhosphorImaging, was defined as one. Relative values were
determined by the simultaneous PCR amplification of a seri-
ally diluted positive control sample (either R1WT or
RIH609LAC1023-1040, whichever was higher) from which a
standard curve was derived. Values obtained in this way were
linear over a 100-fold range for amplification products from
both pJH200 and pJH288. The relative values between two
samples was extremely reproducible when determined from
independent PCR runs with standard curves derived from
different dilution standards (e.g., run I: sample A set at 1.0,
sample B = 0.36; run II: sample A set at 1.0, sample B = 0.34).
The recombination frequency of pJH200 was 1-3% with
R1WT as determined by bacterial transformation and -0.1%
for pJH288. The relative amounts of PCR fragments amplified
from these V(D)J recombined plasmids and their derivatives
reflected these differences.
Protein Analysis. 293 cells plated as described above were
transfected with 20 Ag of the indicated expression vectors.
Nuclei were isolated by incubation of transfected cells (3-4 x
106 cells at the time of harvest) in 0.5 ml of lysis buffer (1%
Nonidet P-40, 10 mM Tris HCl, pH 8.0/10 mM NaCl). Nuclei
were then lysed by sonication in 0.5 ml of lysis buffer plus 0.4
M NaCl, and the insoluble fraction was collected by centrif-
ugation. The insoluble pellets were resuspended by sonication
in 100 ,lI of SDS sample buffer and 1 /1Oth of the samples were
resolved through 10% polyacrylamide gels via SDS/PAGE by
standard procedures (23). Proteins were then transferred to
nitrocellulose membranes, probed with a mouse anti-RAG1
monoclonal antibody (Pharmingen), and visualized with
horseradish peroxidase-conjugated sheep anti-mouse second-
ary antibody (Fisher) developed with ECL (Amersham).
RESULTS
The RAG] genomic locus was originally isolated by its ability
to activate recombination in the fibroblast line 3TGR (2, 24).
3TGR harbors an integrated retroviral recombination sub-
strate (pDGR; ref. 25) that contains a neomycin (neo)-resist-
ance gene, which is dependent on inversion via V(D)J recom-
bination for its transcriptional activation. Two murine RAG1
cDNAs, M2 and M6, were originally isolated (2), but only M2
promoted the formation of neo-resistant colonies of 3TGR; in
contrast, the M6 cDNA was inactive in this assay. Nevertheless,
sequence analysis of M6 failed to reveal any obvious coding
sequence flaw, such as a nonsense mutation. We compared the
complete sequences of M2 and M6 and found that they
differed at only one nucleotide, which resulted in a missense
mutation changing histidine (M2) to leucine (M6) at position
609 (Fig. 1A). Although the published sequence of murine
RAG1 is of M6 (2), sequence comparison of RAG1 from
different species showed that a histidine residue was present at
this position in all other species (compiled in ref. 26). Fur-
thermore, we have independently derived murine RAG1
sequences that contain histidine at this site. Thus, the M2 allele
is most likely the true wild-type murine gene (herein referred
to as RAG1 wild type; R1WT) and M6 a serendipitous variant
(herein referred to as RlH609L).
We tested both alleles to compare their ability to recombine
plasmid substrates in fibroblasts by transient cotransfection
with RAG2. We first tested R1WT and R1H609L with the
plasmid substrate pJH200, a deletion substrate that retains
signal joints after recombination (18) (Table 1). We measured
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aagctcggg
R 1 H609L (M6) aagcacgggK L G
G09
B +RAG-2
pJH200
pJH288 _ _
FIG. 1. Two alleles ofRAG], R1WT and RlH609L, have different
relative activities with different plasmid substrates. (A) Sequence of
murine wild-type RAG1 (R1WT, M2) and R1H609L (M6) from
nucleotides 1916-1924. Nucleotide at position 1920 is indicated in
boldface. R1H609L contains an Ava I restriction site here; this is lost
in the wild-type allele. (B) PCR amplification of fragments derived
from recombination plasmid substrates pJH200 and pJH288. An
autoradiograph of fragments amplified from Hirt plasmid prepara-
tions from cells transfected with either pJH200 (Upper) or pJH288
(Lower) as described. Band representing the fragment created by
V(D)J recombination is indicated with an arrow. RAG expression
vectors included in the transfections are indicated above each lane.
R1HL, RlH609L; RlHLAC, RlH609LAC1023-1040.
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the relative abundance of recombined pJH200 recovered from
transiently transfected cells by PCR amplification of DNA
fragments whose formation depended on V(D)J recombina-
tion (see Materials and Methods). We found that in contrast to
their relative behavior in the 3TGR colony-forming assay, both
R1WT and RlH609L activated recombination of pJH200 (Fig.
1B). As measured by the PCR assay, the relative activity of
RIH609L was -55% that of R1WT (Table 2). We indepen-
dently confirmed the PCR assay results by measuring the
proportion of recombinant plasmids by transformation of
bacteria (data not shown). In parallel, we tested a deletion
mutant of RlH609L, RlH609LAC1023-1040, from which the
C-terminal 17 amino acids was removed (27). This truncation
activated the recombination frequency of the H609L allele by
-7.5-fold and was on average 4-fold more active than full-
length R1WT as measured with pJH200 (Fig. 1B and Table 2;
see below). We carried this allele through with all of the later
recombination substrates because it acts as an independent test
of activity.
In contrast, we observed a striking deficiency of R1H609L
with respect to R1WT in its ability to activate recombination
of pJH288, an inversion substrate that retains both coding and
signal joints (ref. 19; Fig. 1B and Table 2; see below). The
ability of RlH609L to activate recombination in this assay was
only 7% of the activity of R1WT. We also observed a dramatic
reduction in the relative activity of RlH609LAC1023-1040.
This variant activated recombination less efficiently than
R1WT (80% R1WT activity) with pJH288 (Fig. 1B and Table
2; see below). The relative activities of R1WT and RlH609L
as measured by pJH288 mirrored the activity observed using
the 3TGR colony-forming assay.
The different relative activities of the RAG1 alleles were not
due to variations in protein levels. We initially observed that
H609L was expressed at an -5-fold lower steady-state amount
compared to R1WT when both alleles were expressed from the
same expression vector (Fig. 2A). However, we determined
that under our transfection conditions the recombination assay
was indifferent to a >20-fold decrease in the steady-state
amount of wild-type RAG1 and was limiting only for RAG2
(Fig. 2B; data not shown). We confirmed this observation
directly by varying the transfection parameters either by
lowering the amount of RAG-1WT expression vector or by
changing the expression vectors such that both proteins were
expressed at comparable amounts. These changes did not have
a significant effect on the relative activities of the mutant and
wild-type alleles with a panel of recombination substrates (Fig.
2B). Furthermore, indirect immunofluorescence analysis of
R1H609L showed that the protein localized normally within
the nucleus (27). Therefore, the behavior of these RAG1
variants reflected intrinsic differences in their activities. These
results strongly suggested that RAG1 acts directly in the V(D)J
recombination reaction mechanism because different alleles
differentially activated the recombination of different plasmid
substrates.
Since both plasmids tested here contained identical 12- and
23-RSSs, we were interested in understanding what other
Table 2. Comparison of activity of RAG] alleles as measured with
different plasmid V(D)J recombination substrates
Recombination substrate
RAG1 allele pJH200 pJH288 pJH288JV
R1WT 1.000 1.000 1.000
R1H609L 0.553 + 0.082 0.077 + 0.041 0.712 ± 0.122
R1H609LAC 4.153 ± 1.043 0.840 + 0.253 8.06 ± 1.336
Relative activities of the different alleles ofRAG] as determined by
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FIG. 2. Modest changes in RAG1 protein levels do not affect
recombination activity. (A) Western blot analysis of RAG1 proteins
from cells transfected with different RAG1 CDM8 expression vectors.
All RAG1 constructs were in the CDM8 backbone and a total of
20 j,g was used per transfection. +5'UT, CDM8 vector, which contains
the 5' untranslated region of RAG1, was used. Lane 1, empty CDM8
vector was transfected; lane 2, one-fifth the amount (5 jig) of CDM8-
R1WT was transfected and the remainder (15 ,ug) was empty CDM8.
(B) Recombination activity of RAG] alleles expressed from different
constructs. Autoradiograph of fragments amplified from the indicated
samples from one experiment in which they were transfected in
parallel. All transfections included RAG2.
differences between pJH288 and pJH200 could account for the
phenotype of RlH609L. Three major differences in these
plasmids could have been responsible for the effect: (i) the
DNA topology of inversion versus deletion, (ii) the require-
ment of coding joint formation for inversion, and (iii) the
coding-end nucleotide sequence adjacent to the RSS. We
believed the last possibility most likely because it is known that
the coding nucleotides immediately adjacent to the heptamer
could significantly affect recombination frequency by the
wild-type V(D)J recombinase by several orders of magnitude
(8-10). Furthermore, the choice between inversion versus
deletion in one class of plasmid substrates was influenced by
the content of the coding sequences adjacent to the heptamer
sites (9). We noted that pJH288 and pDGR contain the same
sequences abutting the heptamer sites (5'-AC-heptamer or
CC-heptamer; see Table 1) but are different from pJH200
where the sequence is 5'-TG-heptamer.
We therefore changed the coding-end sequence at the
heptamer junctions of pJH288 to those present in pJH200
(Table 1). We first challenged the RAG1 variants with the
plasmid substrate pJH288JV, which contains TG 5' to both
heptamers. Simply changing the sequences of the coding ends
in pJH288 activated the ability of R1H609L to recombine this
substrate >10-fold compared to R1WT (75% the activity of
R1WT; compare Fig. 3 A and B and Table 2). The relative
recombination frequencies of R1WT and R1H609L with this
altered pJH288 substrate were comparable to those with
pJH200. This was reflected in the relative activity of
RIH609LAC1023-1040; this form of RAG1 was also activated
10-fold, which resulted in an activity 8 times higher than R1WT
(Fig. 3 A and B and Table 2). The C-terminal truncation thus
provided independent confirmation of the effect of coding-end
sequence on recombination activity by the H609L allele. As
measured by both pJH288 and pJH288JV, the difference in the
activities of R1H609L and RlH609LAC1023-1040 was >11-
fold. It is evident that the R1H609L variant is sensitive to the
coding sequence adjacent to the heptamer site.
To assess the individual contribution of each coding end to
the recombination activity, we tested the ability of R1WT and
PCR assay, with the value of R1WT set as one. Data represent values
obtained from 3 (pJH200), 6 (pJH288), or 5 (pJH288JV) experiments
+ SD. These values are reiterated in bar-graph format in Figs. 3 and
4.
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R1H609L to activate recombination ofpJH288 derivatives that
contained base substitutions at only the 12-heptamer or 23-
heptamer coding junctions (pJH288V and pJH288J; see Table
1). Changes at single coding ends allowed substantial but
incomplete rescue of R1H609L activity relative to R1WT (Fig.
3C). The effect seemed to be additive because each mutation
allowed 50-60% of the total possible rescue. We also noted
that mutations at the 12-heptamer coding junction seemed to
have a slightly stronger effect on the relative activities of the
two RAGI alleles than those at the 23-heptamer. Both of these
observations were reiterated in the activities of the C-terminal
truncation of R1H609L.
Because changing the coding sequences adjacent to the
heptamer sites in pJH288 was sufficient to render it a signif-
icantly better substrate for R1H609L, we anticipated that
reciprocal mutations in pJH200 would have a conversely
deleterious effect. We first tested the pJH200 derivative
pJH200JV(ApaLI), which contains substitutions of 5'-TG at
both the 12-heptamer and 23-heptamer coding junctions. As
shown in Fig. 4, these changes did indeed repress the recom-
bination activities of R1H609L and RlH609LAC1023-1040
with respect to R1WT. However, in marked contrast to
pJH288, we observed only an -2-fold repressive effect. Thus,
as measured with this plasmid substrate, the activity of
R1H609L was only slightly affected by the two coding-end
nucleotides. Similarly, mutations at either the 12- or 23-
heptamer [plasmids pJH200V(ApaLI) and pJH200J] had little
if any effect (data not shown). Thus, there are contextual
effects that we have yet to understand.
One explanation for this difference is that the initial steps of
recombination-i.e., binding, synapsis, and cleavage-were
not strongly affected by these nucleotide changes. In this
F1-to. Coding scquenc Cs immiiiiediattclv 53' of tthc heptat cr
site profounLdly inf luence relative activ ity of RI H609L as
meaisured by pJI 1288. (A) Rccombination actiCVity aIs meaCsurcd
wvith pJH288. VIluLeC for RI WI' is dlefinccd as one, and activities
of RI I 1609L and RI 116091 AC 102331040 arc represcnted as
fractions of that. Recombination Substrate used is indicated
bhove each graph. and allele of RAGI is indicated below the
graph. Each bar represcnts an individual experimental value
that is indicated abovc cach bar; a representative aUtoradio-
graph is shown. WT. RIWT; H609L or HL. RIH609L;
1-1609LAC or I1LAC. RIH6(09LAC1023-11)40. Middle graph
shows the same data aIs the lirst but with the scale changed feor
comparison. (B) Autoradiographs of fragments amplified fromii
samlplcs indicated aboveeCach lane fronm cells that xverc tranls-
fected with cither pJ1l288 (Uppwr) or pJ 288JV (Lont-r). ((C)
Bar graphs showving relative recombination values as measured
with pJX-1288V and pH1-288J.
scenario, coding-joint formation with those ends may be
hindered by R1H609L and the manifestation of this deficiency
would arise only in pJH288, which must retain coding joints. To
address this issue, we examined the excision products of
pJH200 and its derivatives. We expected that if coding joint
formation were disproportionately affected, the relative
amounts of excision products that contain coding joints should
be significantly different than the plasmid products. We there-
fore designed a PCR-based assay to detect the excised circular
products. As shown in Fig. 5A, excision products that retain
coding joints can be detected from Hirt plasmid preparations
recovered from cells transfected either with pJH200 and
pJH200JV(ApaLI). The relative abundance of these products
paralleled that observed with the respective parental plasmid
substrates (see Fig. 5B). We therefore conclude that coding-
joint formation was not differentially affected by RlH609L.
This observation implied that either inversion of the inter-
vening sequence in pJH288 or other sequence differences
between the plasmid families were affecting recombination
activity. To address the first possibility, we determined the
recombination profile of pJH289, a signal-joint-retaining de-
letion substrate of the same plasmid family as pJH288 (19).
This plasmid had a recombination frequency profile indistin-
guishable from that observed with pJH288 (data not shown),
and thus inversion was not responsible for the differences in
recombination activity observed.
To address the second possibility, we created the substrate
pJH200JV(SalI) to test whether heptamer-proximal nucleo-
tides beyond the two at the coding end might influence
recombination activity of pJH200; pJH288 contains a Sal I
rather than an ApaLI site adjacent to the 12-heptamer (see
Table 1). Although these restriction sites differ only by the
pJH288 pJH288 pJH288JV
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FIG. 4. Coding sequences immediately 5' of the heptamer site have a modest effect on relative activity of R1H609L as measured with pJH200.
pJH200 derivative used to measure activity is indicated above each graph. Otherwise the description and derivation of the graphs are the same
as in Fig. 3.
orientation of the central 2 nucleotides, we did observe an
additional but small (-2-fold) effect by the presence of the Sal
I site (Fig. 4). This effect was more apparent with full-length
R1H609L. Nevertheless, a direct comparison of pJH289 and
pJH200JV(SalI) still revealed on average a 2- to 3-fold differ-
ence in the recombination efficiency profiles (Fig. 6). This
observation suggests that RAG-1 is also sensitive to the third
coding nucleotide and sequences beyond those since they also
subtly influence recombination efficiency.
DISCUSSION
We have serendipitously identified a RAG1 variant, R1H609L,
the activity of which is sensitive to the coding nucleotides
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FIG. 5. Formation of excision products that contain coding joints
is not differentially affected by R1H609L. (A) Autoradiograph of
fragments amplified from excision products by PCR of Hirt superna-
tants from cells transfected with pJH200JV(ApaLI). (B) Bar graph
comparing relative amounts of plasmid (0) and excision (m) products
of pJH200JV(ApaLI) and pJH200 as determined by Phosphor-
Imaging.
adjacent to the heptamer site of the RSS. The behavior of this
mutant strongly implicates RAG1 as a component of the
V(D)J recombinase that is important for substrate recognition
and reiterates the important influence of coding-end content
on recombination efficiency.
We do not yet know how the H609L mutation affects RAG1
structure or what aspect ofDNA recognition is involved. These
parameters include the efficiency of DNA binding, synapsis,
and/or cleavage. Although we have shown an effect of coding-
end sequences and not the RSS proper on the recombination
activity of RAG1, the coding ends can be considered an
extension of the RSS since they are an established part of the
DNA sequence relevant to determining recombination effi-
ciency. The effect of coding end sequence on the recombina-
tion activity by R1H609L reported here may be related to but
is distinct from that observed with the wild-type V(D)J
recombinase. In previous studies, plasmid recombination sub-
strates that contained A or T adjacent to the heptamer site
were shown to have a much lower frequency of recombination
than those with G or C (8, 10, 28). We did observe a 2- to 3-fold
inhibitory effect on the absolute recombination activity of
R1WT by the presence of 5'-TG that replaced 5'-AC and
5'-CC when we compared pJH288 with pJH288JV and pJH200
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FIG. 6. Comparison of RAG1 activity with pJH289 and pJH200
derivatives. Bar graph comparing relative recombination profiles of
pJH289 (A), pJH200JV(ApaLI) (-), and pJH200JV(SalI) (n). These
plasmids share identical RSSs and the two most heptamer-proximal
coding nucleotides.
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with pJH200JV(ApaLI) (data not shown). Our data suggest
that wild-type RAG1 may be responsible for the sequence
sensitivity to those substrates.
One explanation for the behavior of the R1H609L variant is
that this portion of RAG1 may directly contact DNA and that
the leucine moiety is compatible with a different spectrum of
nucleotide sequences than the histidine. Alternatively, the
mutation may affect the conformation of the putative DNA
binding/catalytic domain of RAG1 or interactions with an-
other protein which itself is important for mediating these
activities. Notably, a His-to-Ala substitution at this position did
not elicit the same phenotype as R1H609L and behaved
instead like R1WT (data not shown). Other alanine substitu-
tions near the histidine residue either had no effect (E607A;
data not shown) or reduced the activity of RAG1 with all
substrates (K608A; data not shown).
However, while this manuscript was in preparation, a mutant
of RAG1 was reported by Sadofsky et al. (29) that contains a
2 amino acid replacement of 4 amino acids that span positions
606-611. This mutant had a phenotype similar to but much
more severe than the R1H609L variant. Nevertheless, the
coding-end sequence dependence of the two mutants appears
to be similar and therefore most likely affects the same aspect
of substrate recognition. These two independently derived
RAG1 mutants are so far unique and underscore the impor-
tance of this region in influencing DNA recognition.
Although the coding sequence composition had a 10-fold
effect on the relative recombination activity elicited by
R1H609L, we observed this strong a manifestation of coding-
sequence alteration only within the context of pJH288. Re-
ciprocal mutations in pJH200, which extended its coding-end
identity with pJH288 and pJH289 to 6 nucleotides, did have a
repressive effect on the recombination frequency of pJH200 by
R1H609L. However, the effect was not as pronounced as with
pJH288. Since the differences in recombination activities are
relative, it is possible that the parental pJH200 vector itself may
not contain the optimal sequences required for its full recom-
bination potential and the effect of the nucleotide changes we
introduced may not able to exert any more severe an effect in
that context. Nevertheless, our results suggest that other DNA
sequences outside of the RSS and the coding-end nucleotides
can have a modest impact on recombination efficiency.
Our data provide strong evidence to support a model in
which RAG1 is important for RSS recognition. RAG1 may
directly contact the DNA molecule, or it may be a component
of a DNA binding complex even though it may not contact
DNA directly. We consider this latter possibility less likely
given the subtlety of the mutations in both RAG1 and the
recombination substrates. Although we have identified a role
for RAG1 in DNA target site specificity, it does not preclude
the possibility that RAG1 also contributes to other functions,
such as DNA cleavage and activation or organization of other
proteins involved in the complete recombination reaction.
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